沙龙茶会 | 跨界创新 · 中国生物医药公司进军美国策略
随着中国生物医药产业的发展，企业频频“走出国门”，选择在境外资本上市。3月14日，美国德茂律师事务所将举办中美跨国业务法律和策略研讨会。聚焦中国生物医药公司进入美国进行跨国合作的法律、投资和IP策略，欢迎客官们参加！
Innovation Across Borders:
Strategies for Chinese Life Sciences Companies
Doing Business in the U.S.
诚挚邀请:
跨界创新 · 中国生物医药公司进军美国策略
Thursday, 14 March 2019 | 08:30 to 13:30
The Rize-Carlton Shanghai, Pudong
Shanghai IFC, 8 Century Avenue, Lujiazui, Pudong
Shanghai, 200120 China
A buffet luncheon will follow the program.
ABOUT THE PROGRAM
Join us for a discussion on handling cross-border transactions between the U.S. and China. Our panelists will review legal, investment and IP strategies for Chinese life sciences companies bringing products and services to the United States for cross-border collaborations.
AGENDA
Registration and Coffee : 8:30 to 9:00
9:00 to 9:20 Introductory Remarks
Mr. Leon Yee,余启贤 Chairman and Managing Director, Duane Morris & Selvam LLP
Mr. Xiaomeng Sun, 孙晓勐 President, Suzhou BioTOP Technical Service Co., Ltd.
Panel 1: Entering the U.S. Market: Considerations for
Strategic Transactions and Collaborations
在美战略业务与合作的策略考量
9:30 to 10:30
Panelists
Sandra Stoneman, Partner, Duane Morris LLP
Frederick (Rick) Ball, Partner, Duane Morris LLP
Dr. Richard Thurston, Of Counsel, Duane Morris LLP and Duane Morris & Selvam Taiwan
David Chen, 陈大东 Founder & Chairman, BFC Group
Break: 10:30 to 10:45
Panel 2: IP Strategies for the U.S. Market
针对美国市场的IP策略
10:45 to 12:00
Panelists
Dr. Kening Li, 李克宁 Director, Duane Morris & Selvam LLP; Partner, Duane Morris LLP
Mr. Xie WANG, 王勰 Vice President, Suzhou BioBAY and Chairman, Suzhou BioTOP
Anthony Fitzpatrick, Partner, Duane Morris LLP
Christopher Kroon, Partner, Duane Morris LLP
Dr. Haiyan Chen, 陈海燕 Former IP Director, GSK China
Networking and Buffet Luncheon: 12:00 to 13:30
如需注册报名，请点击“阅读原文”。
来源：德茂欣律师事务所上海代表处